GI Stool Testing Market Share

Statistics for the 2023 & 2024 GI Stool Testing market share, created by Mordor Intelligence™ Industry Reports. GI Stool Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Gastroenterology Diagnostics Research GI Stool Examination Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of GI Stool Testing Industry

The GI stool testing market is fragmented in nature, with the presence of major players in the market. Collaborations, mergers, and acquisitions by companies related to GI stool testing are expected to boost market growth. Some of the companies which are currently dominating the GI stool testing market are bioMérieux SA, DiaSorin SpA, Cenegenics Corporation, Abbott Laboratories, Epitope Diagnostics Inc., Genova Diagnostics, Danaher Corporation (Beckman Coulter Inc.), ScheBo Biotech AG, CTKBiotech Inc. Inc., and Cardinal Health.

GI Stool Testing Market Leaders

  1. Abbott Laboratories

  2. Genova Diagnostics

  3. bioMérieux SA

  4. Cardinal Health

  5. Danaher Corporation (Beckman Coulter, Inc.)

*Disclaimer: Major Players sorted in no particular order

GI Stool Testing Market Concentration

GI Stool Testing Market Report Snapshots

Gastrointestinal Infection Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)